Robust evidence for e-cigarettes’ effectiveness as aids to smoking cessation effectiveness has until now been sparse. But that may have changed, if the conclusions of a large study published in the journal Addiction prove to be correct in the long term.
With two years still to run before the European Tobacco Products Directive (TPD) comes into practical force, there are hints already that regulation will bring about a consolidation in major e-cigarette markets.
A nasty surprise could await those who believe that Fontem’s patent litigation against an assortment of e-cigarette makers will be rendered irrelevant by the U.S. market moving to open-tank system designs, not covered by the patents concerned.
British pharmacies have yet to fully exploit the retail opportunities presented by e-cigarettes, according to a prominent market researcher, although pharmacy professionals themselves disagree vehemently over how to approach e-cigs that aren’t medically licensed.
E-cigarettes are on the agenda for a host of trade and professional conferences over the coming weeks, reflecting the urgent need for understanding of new regulatory measures as well as the sector’s development and improving scientific knowledge about the products.
A new survey on e-cigarette usage in the UK from pressure group Action on Smoking and Health (ASH) highlights the extent of dual use with tobacco, and the differing product choices of current and former smokers.
The new regulations for e-cigarettes proposed yesterday by the U.S. Food and Drug Administration (FDA) are the second major regulatory framework for the products to appear in two months, following the European Union’s release of its revised Tobacco Products Directive (TPD) earlier this year. How do the two compare in key areas?
The European Union (EU) does not plan to issue detailed guidance on how e-cigarette regulations in the recent Tobacco Products Directive (TPD) should be interpreted, according to a source close to the EU’s Directorate General for Health and Consumer Affairs (SANCO)
U.S. e-cig manufacturer Victory Electronic Cigarettes is further strengthening its position in the European market with the acquisition of British counterpart VIP, the second UK firm it has bought this year.
The European Parliament’s new rules on e-cigarettes in the Tobacco Products Directive (TPD) have grabbed the attention of key members of the U.S. Senate, generating mixed reactions on whether it should influence the efforts of the Food and Drug Administration (FDA) to regulate the products.
The man who leads the Framework Convention on Tobacco Control (FCTC) at the World Health Organization (WHO) wants to see e-cigarettes brought into the international agreement, according to a news report today.
E-cigarettes made the headlines today in Britain, and they weren’t good ones. The Sun, the nation’s biggest-selling daily newspaper, ran a story headlined “E-Cig Gran Blown Up In Hospital” on its front page.
The Spanish e-cigarette sector is now working under national-level regulation for the first time, after the introduction of a new law which anticipates the measures required by the European Tobacco Products Directive.
The European Commission is expected to issue technical specifications on the measurement of nicotine intake from e-cigarettes, as member states’ law-makers and the industry prepare to comply with the testing requirements of the EU’s new Tobacco Products Directive (TPD).
A Member of the European Parliament involved in the drafting of the EU’s new Tobacco Products Directive (TPD) has criticised the finally adopted version, which the Parliament voted for in late February, as “hastily-drafted and heavy-handed”.
A British right-wing political party received £36,000 ($60,000) in donations from an e-cigarette manufacturer before its leader appeared in a YouTube video apparently designed to influence European policy-making on e-cigs.